Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7068]

Precision therapy enasidenib effective in treating deadly form of leukaemia

Precision therapy enasidenib effective in treating deadly form of leukaemia

Immunotherapy drug effective for metastatic triple negative breast cancer

Immunotherapy drug effective for metastatic triple negative breast cancer

Researchers report encouraging results from combination therapy in Hodgkin lymphoma

Researchers report encouraging results from combination therapy in Hodgkin lymphoma

New target found to attack an incurable brain tumour in children

New target found to attack an incurable brain tumour in children

ASCO 2017: Early research suggests first immunotherapy for mesothelioma on the horizon

ASCO 2017: Early research suggests first immunotherapy for mesothelioma on the horizon

ASCO 2017: Car T-cell therapy sends multiple myeloma into lasting remission

ASCO 2017: Car T-cell therapy sends multiple myeloma into lasting remission

ASCO 2017: Adding a second HER2 blocker may lower chance of invasive breast cancer for some women

ASCO 2017: Adding a second HER2 blocker may lower chance of invasive breast cancer for some women

ASCO 2017: Alectinib halts lung cancer growth more than a year longer than crizotinib

ASCO 2017: Alectinib halts lung cancer growth more than a year longer than crizotinib

ASCO 2017: Web-based system for self-reporting symptoms helps patients live longer

ASCO 2017: Web-based system for self-reporting symptoms helps patients live longer

ASCO 2017: Olaparib slows growth of BRCA-related metastatic breast cancer

ASCO 2017: Olaparib slows growth of BRCA-related metastatic breast cancer

More from ecancer